Gabelli Funds’s Wave Life Sciences WVE Stock Holding History

Gabelli Funds’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,500	Closed	-$127K	–	1345
2026 Q1	$127K	Buy	+17,500	New	+$228K	﹤0.01%	1175

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Gabelli Funds's WVE Position: Q2 2026 in Review

Gabelli Funds sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 17,500 shares — an estimated $127K sold.

Gabelli Funds first reported a position in WVE in Q1 2026 and held it in 1 quarter. The position peaked at $127K in Q1 2026. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Gabelli Funds reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
Gabelli Funds sold 17,500 Wave Life Sciences shares in Q2 2026, an estimated $127K.
Gabelli Funds first reported a position in Wave Life Sciences in Q1 2026 and held it in 1 quarter.
Gabelli Funds's Wave Life Sciences position peaked at $127K in Q1 2026.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.